Scandinavian ChemoTech receives order from Gold Lite in Myanmar
Scandinavian ChemoTech AB has today received an order of EUR 20,000 from Gold Lite Myanmar.
Gold Lite in Singapore, a sister company to ABEX in Malaysia, is responsible for all the operations in Myanmar. The delivery and launch of IQwave™ and D-EECT in Myanmar is scheduled to take place at the end of the current year.
Once again ABEX and Gold Lite demonstrates the targeted cooperation and great commitment against ChemoTech and IQwave™, says Mohan Frick, CEO of ChemoTech.
For more information, please contact:
Mohan Frick, CEO
+46 (0)10-218 93 00
This information is such information which Scandinavian ChemoTech AB (publ) are obligated to make public according to EU’s market abuse regulation. The information was submitted by the agency of above stated contact person, to be made public on Friday 28th of September 2018 at 12.30 (CET).
Scandinavian ChemoTech AB (publ)
ChemoTech is a young and dynamic life science company that possesses a great medical expertise and technical knowledge. Our latest launch of IQwave™ is an innovation within electrochemotherapy, that is adapted for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered in Malmö, in the midst of the medical technology expansionary Öresund region.